Anti-FFAR2/ FFA2R/ GPR43 monoclonal antibody

Anti-FFAR2/ FFA2R/ GPR43 antibody for FACS & in-vivo assay

Target products collectionGo to FFAR2/FFAR2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T28213-Ab-1/ GM-Tg-hg-T28213-Ab-2Anti-Human FFAR2 monoclonal antibodyHuman
GM-Tg-rg-T28213-Ab-1/ GM-Tg-rg-T28213-Ab-2Anti-Rat FFAR2 monoclonal antibodyRat
GM-Tg-mg-T28213-Ab-1/ GM-Tg-mg-T28213-Ab-2Anti-Mouse FFAR2 monoclonal antibodyMouse
GM-Tg-cynog-T28213-Ab-1/ GM-Tg-cynog-T28213-Ab-2Anti-Cynomolgus/ Rhesus macaque FFAR2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T28213-Ab-1/ GM-Tg-felg-T28213-Ab-2Anti-Feline FFAR2 monoclonal antibodyFeline
GM-Tg-cang-T28213-Ab-1/ GM-Tg-cang-T28213-Ab-2Anti-Canine FFAR2 monoclonal antibodyCanine
GM-Tg-bovg-T28213-Ab-1/ GM-Tg-bovg-T28213-Ab-2Anti-Bovine FFAR2 monoclonal antibodyBovine
GM-Tg-equg-T28213-Ab-1/ GM-Tg-equg-T28213-Ab-2Anti-Equine FFAR2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T28213-Ab-1/ GM-Tg-hg-T28213-Ab-2; GM-Tg-rg-T28213-Ab-1/ GM-Tg-rg-T28213-Ab-2;
GM-Tg-mg-T28213-Ab-1/ GM-Tg-mg-T28213-Ab-2; GM-Tg-cynog-T28213-Ab-1/ GM-Tg-cynog-T28213-Ab-2;
GM-Tg-felg-T28213-Ab-1/ GM-Tg-felg-T28213-Ab-2; GM-Tg-cang-T28213-Ab-1/ GM-Tg-cang-T28213-Ab-2;
GM-Tg-bovg-T28213-Ab-1/ GM-Tg-bovg-T28213-Ab-2; GM-Tg-equg-T28213-Ab-1/ GM-Tg-equg-T28213-Ab-2
Products NameAnti-FFAR2 monoclonal antibody
Formatmab
Target NameFFAR2
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-FFAR2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species FFAR2/ FFA2R/ GPR43 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP003179human FFAR2 Lentivirus plasmid
    ORF Viral VectorvGMLP003179human FFAR2 Lentivirus particle
    ORF Viral VectorpGMAD000023rat Ffar2 Adenovirus plasmid
    ORF Viral VectorpGMLPm004489mouse Ffar2 Lentivirus plasmid
    ORF Viral VectorvGMAD000023rat Ffar2 Adenovirus particle
    ORF Viral VectorvGMLPm004489mouse Ffar2 Lentivirus particle


    Target information

    Target IDGM-T28213
    Target NameFFAR2
    Gene ID2867,233079,292794,709026,484580,101082709
    Gene Symbol and SynonymsFFA2R,FFAR2,GPCR43,GPR43
    Uniprot AccessionO15552,Q76EI6
    Uniprot Entry NameFFAR2_HUMAN,FFAR2_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000126262
    Target ClassificationN/A

    The target: FFAR2, gene name: FFAR2, also named as FFA2R, GPR43. This gene encodes a member of the GP40 family of G protein-coupled receptors that are clustered together on chromosome 19. The encoded protein is a receptor for short chain free fatty acids and may be involved in the inflammatory response and in regulating lipid plasma levels. [provided by RefSeq, Apr 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.